89 related articles for article (PubMed ID: 3590115)
1. Identification of a low molecular weight polypeptide of pregnant bovine uterine origin (LMW-UDF): influence on coagulation system in vitro. Part I.
Speidel MT; Suzuki M; Pantazis CG
Thromb Res; 1987 Apr; 46(1):77-87. PubMed ID: 3590115
[TBL] [Abstract][Full Text] [Related]
2. Purification and properties of a mammary-uterine-pituitary tumor cell growth factor from pregnant sheep uterus.
Ikeda T; Sirbasku DA
J Biol Chem; 1984 Apr; 259(7):4049-64. PubMed ID: 6706991
[TBL] [Abstract][Full Text] [Related]
3. Bovine early pregnancy factor (EPF) activity dependent on a 67-kDa polypeptide.
Klima F; Tiemann U; Schadow D; Fasinski M; Savoly SB; Loose R; Pitra C
J Reprod Immunol; 1992 Jan; 21(1):57-70. PubMed ID: 1734078
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of heparin-binding growth factors from porcine uterus.
Brigstock DR; Heap RB; Barker PJ; Brown KD
Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377
[TBL] [Abstract][Full Text] [Related]
5. [Use of low molecular-weight heparin in hemodialysis patients].
Schrader J; Rieger J; Müschen H; Stibbe W; Köstering H; Kramer P; Scheler F
Klin Wochenschr; 1985 Jan; 63(2):49-55. PubMed ID: 3981950
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of human and bovine platelet factor 4.
Wu VY; Walz DA; McCoy LE
Prep Biochem; 1977; 7(6):479-93. PubMed ID: 343096
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism.
Barbanti M; Calanni F; Milani MR; Marchi E; Semeraro N; Colucci M
Thromb Haemost; 1993 Feb; 69(2):147-51. PubMed ID: 8456427
[TBL] [Abstract][Full Text] [Related]
9. A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence.
Milner PG; Li YS; Hoffman RM; Kodner CM; Siegel NR; Deuel TF
Biochem Biophys Res Commun; 1989 Dec; 165(3):1096-103. PubMed ID: 2610682
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
Samama M; Castel M; Matsuo O; Hoylaerts M; Lijnen HR
Thromb Haemost; 1982 Feb; 47(1):36-40. PubMed ID: 7041325
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of proteolytic fragments derived from the C-terminal regions of bovine fibrinogen.
Litvinovich SV; Henschen AH; Krieglstein KG; Ingham KC; Medved LV
Eur J Biochem; 1995 May; 229(3):605-14. PubMed ID: 7758453
[TBL] [Abstract][Full Text] [Related]
12. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
[TBL] [Abstract][Full Text] [Related]
13. The inactivation of hemostatic factors by hematin.
Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
[TBL] [Abstract][Full Text] [Related]
14. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
Lipinski B; Lipinska I
Magnes Res; 2000 Dec; 13(4):233-7. PubMed ID: 11153893
[TBL] [Abstract][Full Text] [Related]
15. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
16. Appearance of platelet-clumping activity in heparinized plasma after acidification--it's mainly due to aggregation of fibrinogen.
Yamamoto N; Tanoue K; Yamazaki H
Thromb Res; 1984 Oct; 36(2):103-12. PubMed ID: 6438826
[TBL] [Abstract][Full Text] [Related]
17. Bound thrombin from crushed clots is composed of alpha-thrombin and the N-terminal regions of alpha- and gamma-chains of fibrinogen.
Kinjoh K; Nakamura M; Gang Z; Sunagawa M; Eguchi Y; Kosugi T
Pathophysiol Haemost Thromb; 2002; 32(4):165-73. PubMed ID: 12759517
[TBL] [Abstract][Full Text] [Related]
18. Uptake of 125I-Lys-plasminogen by in vitro thrombi.
Iga Y; Greenwald SR; Chandler AB
Haemostasis; 1983; 13(1):25-35. PubMed ID: 6840626
[TBL] [Abstract][Full Text] [Related]
19. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
[TBL] [Abstract][Full Text] [Related]
20. Isolation and partial characterization of a cystine-rich basic heparin-binding protein from bovine platelets.
Szabó E; Muszbek L
Biochem Biophys Res Commun; 1991 Jan; 174(1):70-6. PubMed ID: 1989621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
